Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Large conductance calcium-activated potassium channel SLO-1, also known as the BK channel, is a critical regulator of cellular excitability in both neurons and muscle cells [1, 13]. It is uniquely gated by both membrane depolarization and increases in intracellular calcium concentration, allowing it to integrate electrical and chemical signals to modulate repolarization [13, 18]. In nematodes, SLO-1 is the primary molecular target for the anthelmintic drug emodepside, which activates the channel to cause hyperpolarization and flaccid paralysis [2, 3]. While essential for parasite control, the channel's human ortholog, KCNMA1, is involved in vital processes such as smooth muscle relaxation and neurotransmitter release [13, 16]. Consequently, therapeutic strategies targeting SLO-1 must achieve high selectivity to avoid host toxicities associated with human BK channel dysfunction, such as epilepsy or movement disorders [13, 16]. Therapeutic development focuses on exploiting structural differences between nematode and mammalian channels to ensure safety [2, 12].
Emodepside acts as a potent activator of the SLO-1 channel, increasing its open probability and leading to a massive efflux of potassium ions. This causes membrane hyperpolarization, which inhibits neuronal and muscle activity, resulting in flaccid paralysis and death of the nematode [1, 2, 4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large conductance calcium-activated potassium channel SLO-1 (SLO-1).